rezlidhia

Generic: olutasidenib

Labeler: rigel pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name rezlidhia
Generic Name olutasidenib
Labeler rigel pharmaceuticals, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

olutasidenib 150 mg/1

Manufacturer
Rigel Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 71332-005
Product ID 71332-005_6df73356-e3c1-498d-af08-c34b5d257bdb
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA215814
Listing Expiration 2026-12-31
Marketing Start 2022-12-01

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71332005
Hyphenated Format 71332-005

Supplemental Identifiers

RxCUI
2623648 2623654
UNII
0T4IMT8S5Z

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rezlidhia (source: ndc)
Generic Name olutasidenib (source: ndc)
Application Number NDA215814 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE (71332-005-01)
source: ndc

Packages (1)

71332-005-01 30 CAPSULE in 1 BOTTLE (71332-005-01)

Ingredients (1)

olutasidenib (150 mg/1)

Linked Drug Pages (1)

REZLIDHIA ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "6df73356-e3c1-498d-af08-c34b5d257bdb", "openfda": {"unii": ["0T4IMT8S5Z"], "rxcui": ["2623648", "2623654"], "spl_set_id": ["4a0c7c8b-b95f-455d-9600-b7351e4397fe"], "manufacturer_name": ["Rigel Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (71332-005-01)", "package_ndc": "71332-005-01", "marketing_start_date": "20221201"}], "brand_name": "REZLIDHIA", "product_id": "71332-005_6df73356-e3c1-498d-af08-c34b5d257bdb", "dosage_form": "CAPSULE", "product_ndc": "71332-005", "generic_name": "olutasidenib", "labeler_name": "Rigel Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "REZLIDHIA", "active_ingredients": [{"name": "OLUTASIDENIB", "strength": "150 mg/1"}], "application_number": "NDA215814", "marketing_category": "NDA", "marketing_start_date": "20221201", "listing_expiration_date": "20261231"}